18 F-FLT-PET for response evaluation of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with solid tumors

Selumetinib (AZD6244, ARRY-142886) is a potent, selective, uncompetitive inhibitor of MEK 1 / 2, part of the RAF/MEK/ERK protein kinase signal cascade, which is responsible for tumor. This pilot study was used to explore if 18  F-fluoro-l-thymidine (FLT), a thymidine analogue positron emission tomog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ingrid Desar, Rozemarie Gilles, Carla van Herpen, Anja J. Timmer-Bonte, Mireille Cantarini, Winette van der Graaf, Wim Oyen
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Medknow Publications 2012-04-01
Colecção:World Journal of Nuclear Medicine
Assuntos:
f-18 flt
pet-ct
selumetinib
treatment response
Acesso em linha:http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.103413
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados